Two things jump out at me. One: This is POET technology, not PET, so we have the optical going. Two: We have a viable sourse (probably a brand new process) for Gallium Arsinide wafers. Also, of course there is a new direction for the company. Our new BoD is very knowledgable and are setting the sights/goals much higher than we had before, as our guys can see what we really have. Previously the sights were set too low. I think our leaders are going to capitalize POET Technology to its fullest extent. We may hear something from the BAE deal even before the September date. All my opinion, but to me well founded. B/T. We may have those milestones completed but management wants to keep some leverage. I'd call the NR a positive. The market will figure it out.